Mitochondria and familial predisposition to breast cancer

Current Genomics

Volumn 14, Issue 3, 2013, Pages 195-203

  Weig, Stefania ^a   Paradiso, Angelo ^a   Tommasi, Stefania ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Dna variations; Hereditary breast cancer; Mitochondrial dna; Mitochondrial haplogroup; Polymorphism

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CYTOCHROME B; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RNA 16S; SIRTUIN;

ALLELE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE PREDISPOSITION; DNA DAMAGE; DNA POLYMORPHISM; ENERGY METABOLISM; GENE EXPRESSION; GENE MUTATION; HUMAN; MITOCHONDRIAL GENE; MITOCHONDRIAL GENOME; OXIDATIVE PHOSPHORYLATION;

EID: 84878633311     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202911314030005     Document Type: Article

References (122)

1. Anderson, S.; Bankier, A.T.; Barrell, B.G.; De Bruijn, M.H.L.; Coulson, A.R.; Drouin, J.; Eperon, I.C.; Nierlich, D.P.; Roe, B.A.; Sanger, F.; Schreier, P.H.; Smith, A.J.H.; Staden, R.; Young, I.G. Sequence and organization of the human mitochondrial genome. Nature, 1981, 290, 457-465.
2. De Giorgi, C.; Saccone, C. Mitochondrial genome in animal cells. Structure, organization, and evolution. Cell Biophys., 1989, 14(1), 67-78.
3. Pesole, G.; Gissi, C.; De Chirico, A.; Saccone, C. Nucleotide substitution rate of mammalian mitochondrial genomes. J. Mol. Evol., 1999, 48(4), 427-434.
4. Neiman, M.; Taylor, D.R. The causes of mutation accumulation in mitochondrial genomes. Proc. Biol. Sci., 2009, 276(1660), 1201-1209.
5. Spelbrink, J.N. Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges. IUBMB Life, 2010, 62, 19-32.
6. Jenuth, J.P.; Peterson, A.C.; Fu, K.; Shoubridge E.A. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat. Genet., 1996, 14(2), 146-151.
7. Chinnery, P.F.; Thorburn, D.R.; Samuels, D.C.; White, S.L.; Dahl, H.M.; Turnbull, D.M.; Lightowlers, R.N.; Howell, N. The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet., 2000, 16(11), 500-505.
8. Strachan, T.; Read, A.P. The mitochondrial genome is a hotspot for pathogenic mutations, In: Human Molecular Genetics, 3rd ed.; Garland Sciences Ed.; 29 West 35th Street, NY, 2003; pp. 333-334.
9. Petros, J. A.; Baumann, A.K.; Ruiz-Pesini, E.; Amin, M.B.; Sun, C.Q.; Hall, J.; Lim, S.; Issa, M.M.; Flanders, W.D.; Hosseini, S.H.; Marshall, F.F.; Wallace, D.C. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. U.S.A., 2005, 102(3), 719-724.
10. Singh, K.K. Mitochondria damage checkpoint, aging, and cancer. 2006. Ann. N.Y. Acad. Sci., 2006, 1067, 182-190.
11. Ishikawa, K.; Takenaga, K.; Akimoto, M.; Koshikawa, N.; Yamaguchi, A.; Imanishi, H.; Nakada, K.; Honma, Y.; Hayashi, J. ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 2008, 320, 661-664.
12. Brandon, M.; Baldi, P.; Wallace, D.C. Mitochondrial mutations in cancer. Oncogene, 2006, 25(34), 4647-4662.
13. Treuting, P.M.; Linford, N.J.; Knoblaugh, S.E.; Emond, M.; Morton, J.F.; Martin, G.M.; Rabinovitch, P.S.; Ladiges, W.C. Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J. Gerontol. A Biol. Sci. Med. Sci., 2008, 63(8), 813-822.
14. Ha, P.K.; Tong, B.C.; Westra, W.H.; Sanchez-Cespedes, M.; Parrella, P.; Zahurak, M.; Sidransky, D.; Califano, J.A. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin. Cancer Res., 2002, 8, 2260-2265.
15. Dasgupta, S.; Yung, R.C.; Westra, W.H.; Rini, D.A.; Brandes, J.; Sidransky, D. Following mitochondrial footprints through a long mucosal path to lung cancer. PLoS One, 2009, 4(8), e6533.
16. Sharma, H.; Singh, A.; Sharma, C.; Jain, S.K.; Singh, N. Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer. Cancer Cell Int., 2005, 5, 34.
17. Warburg, O. On the origin of cancer cells. Science, 1956, 123(3191), 309-314.
18. Ericson, N.G.; Kulawiec, M.; Vermulst, M.; Sheahan, K.; O'Sullivan, J.; Salk, J.J.; Bielas, J.H. Decreased mitochondrial DNA mutagenesis in human colorectal cancer. PLoS Genet., 2012, 8(6), e1002689.
19. Levine, A.J.; Puzio-Kuter, A.M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science, 2010, 330(6009), 1340-1344.
20. Gredilla, R. DNA damage and base excision repair in mitochondria and their role in aging. J. Aging Res., 2011, 257093.
21. Singh, K.K. Mitochondrial dysfunction is a common phenotype in aging and cancer. Ann. N.Y. Acad. Sci., 2004, 1019, 260-264.
22. Shidara, Y.; Yamagata, K.; Kanamori, T.; Nakano, K.; Kwong, J.Q.; Manfredi, G.; Oda, H.; Ohta, S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res., 2005, 65, 1655-1663.
23. Fogg, V.C.; Lanning, N.J.; Mackeigan, J.P. Mitochondria in cancer: at the crossroads of life and death. Chin. J. Cancer, 2011, 30(8), 526-539.
24. Berridge, M.V.; Herst, P.M.; Lawen, A. Targeting mitochondrial permeability in cancer drug development. Mol. Nutr. Food Res., 2009, 53(1), 76-86.
25. Gogvadze, V. Targeting mitochondria in fighting cancer. Curr. Pharm. Des., 2011, 17(36), 4034-4046.
26. Grimm, D.; Wehland, M.; Pietsch, J.; Infanger, M.; Bauer, J. Drugs interfering with apoptosis in breast cancer. Curr. Pharm. Des., 2011, 17(3), 272-283.
27. Constance, J.E, Lim, C.S. Targeting malignant mitochondria with therapeutic peptides. Ther. Deliv., 2012, 3(8), 961-979.
28. Seoane, M.; Mosquera-Miguel, A.; Gonzalez, T.; Fraga, M.; Salas, A.; Costoya, J.A. The mitochondrial genome is a genetic sanctuary during the oncogenic process. PLoS One, 2011, 6(8), e23327.
29. Cipollini, G.; Tommasi, S.; Paradiso, A.; Aretini, P.; Bonatti, F.; Brunetti, I.; Bruno, M.; Lombardi, G.; Schittulli, F.; Sensi, E.; Tancredi, M.; Bevilacqua, G.; Caligo, M.A. Genetic alterations in hereditary breast cancer. Ann. Oncol., 2004, 15(1), I7-I13.
30. Poumpouridou, N.; Kroupis, C. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges. Clin. Chem. Lab. Med., 2011, 50(3), 423-434.
31. Shuen, A.Y.; Foulkes, W.D. Inherited mutations in breast cancer genes--risk and response. J. Mammary Gland Biol. Neoplasia, 2011, 16(1), 3-15.
32. Fliss, M.S.; Usadel, H.; Caballero, O.L.; Wu, L.; Buta, M.R.; Eleff, S.M.; Jen, J.; Sidransky, D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science, 2000, 287(5460), 2017-2019.
33. Parrella, P.; Xiao, Y.; Fliss, M.; Sanchez-Cespedes, M.; Mazzarelli, P.; Rinaldi, M.; Nicol, T.; Gabrielson, E.; Cuomo, C.; Cohen, D.; Pandit, S.; Spencer, M.; Rabitti, C.; Fazio, V.M.; Sidransky, D. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res., 2001, 61(20):7623-7626.
34. Rohan, T.E.; Wong, L.J.; Wang, T.; Haines, J.; Kabat, G.C. Do alterations in mitochondrial DNA play a role in breast carcinogenesis? J. Oncol., 2010, 604304.
35. Chatterjee, A.; Dasgupta, S.; Sidransky, D. Mitochondrial subversion in cancer. Cancer Prev. Res., 2011, 4(5), 638-654.
36. Wallace, D.C. Mitochondria and cancer. Nat. Rev. Cancer, 2012, 12(10), 685-698.
37. Zhao, J.; Zhang, J.; Yu, M.; Xie, Y.; Huang, Y.; Wolff, D.W.; Abel, P.W.; Tu, Y. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene, 2012, doi: 10.1038/onc.2012.494.
38. Mourier, T.; Hansen, A. J.; Willerslev, E.; Arctander, P. The Human Genome Project reveals a continuous transfer of large mitochondrial fragments to the nucleus. Mol. Biol. Evol., 2001, 18, 1833-1837.
39. Ramos, A.; Barbena, E.; Mateiu, L.; del Mar González, M.; Mairal, Q.; Lima, M.; Montiel, R.; Aluja, M.P.; Santos, C. Nuclear insertions of mitochondrial origin: database updating and usefulness in cancer studies. Mitochondrion, 2011, 11, 946-953.
40. Hazkani-Covo, E.; Zeller, R.M.; Martin, W. Molecular poltergeists: mitochondrial DNA copies (numts) in sequenced nuclear genomes. PLoS Genet., 2010, 6, e1000834.
41. Lang, M.; Sazzini, M.; Calabrese, F.M.; Simone, D.; Boattini, A.; Romeo, G.; Luiselli, D.; Attimonelli, M.; Gasparre, G. Polymorphic Numts trace human population relationships. Hum. Genet., 2012, 131, 757-771.
42. Parr, R.L.; Maki, J.; Reguly, B.; Dakubo, G.D.; Aguirre, A.; Wittock R.; Robinson K.; Jakupciak, J.P.; Thayer, R.E. The pseudomitochondrial genome influences mistakes in heteroplasmy interpretation. BMC Genomics, 2006, 7, 185.
43. Ellinger, J.; Müller, D.C.; Müller, S.C.; Hauser, S.; Heukamp, L.C.; von Ruecker, A.; Bastian, P.J.; Walgenbach-Brunagel, G. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. Urol. Oncol., 2012, 30(4), 509-515.
44. Parr, R.L.; Dakubo, G.D.; Crandall, K.A.; Maki, J.; Reguly, B.; Aguirre, A.; Wittock, R.; Robinson, K.; Alexander, J.S.; Birch-Machin, M.A.; Abdel-Malak, M.; Froberg, M.K.; Diamandis, E.P.; Thayer, R.E. Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to agematched prostate samples without malignant histology. J. Mol. Diagn., 2006, 8, 312-319.
45. Maki, J.; Robinson, K.; Reguly, B.; Alexander, J.; Wittock, R.; Aguirre, A.; Diamandis, E.P.; Escott, N.; Skehan, A.; Prowse, O.; Thayer, R.E.; Froberg, M.K.; Wilson, M.J.; Maragh, S.; Jakupciak, J.P.; Wagner, P.D.; Srivastava, S.; Dakubo, G.D.; Parr, R.L. Mitochondrial genome deletion aids in the identification of false-and true-negative prostate needle core biopsy specimens. Am. J. Clin. Pathol., 2008, 129, 57-66.
46. Schon, E.A.; Dimauro, S.; Hirano, M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet., 2012, 13(12), 878-890.
47. Jerónimo, C.; Nomoto, S.; Caballero, O.L.; Usadel, H.; Henrique, R.; Varzim, G.; Oliveira, J.; Lopes, C.; Fliss, M.S.; Sidransky, D. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene, 2001, 20(37), 5195-5198.
48. Zhu, W.; Qin, W.; Wessel, A.; Puckett, C.L.; Sauter, E. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis, 2005, 26(1), 145-152.
49. Yu, M.; Shi, Y.; Zhang, F.; Zhou, Y.; Yang, Y.; Wei, X.; Zhang, L.; Niu, R. Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J. Biomed. Sci., 2008, 15(4), 535-543.
50. Lee, H.C.; Yin, P.H.; Lin, J.C.; Wu, C.C.; Chen, C.Y.; Wu, C.W.; Chi, C.W.; Tam, T.N.; Wei, Y.H. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann. N.Y. Acad. Sci., 2005, 1042, 109-122.
51. Zhao, Y.B.; Yang, H.Y.; Zhang, X.W.; Chen, G.Y. Mutation in Dloop region of mitochondrial DNA in gastric cancer and its significance. World J. Gastroenterol., 2005, 11(21), 3304-3306.
52. Lee, H.C.; Li, S.H.; Lin, J.C.; Wu, C.C.; Yeh, D.C.; Wei, Y.H. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res., 2004, 547(1-2), 71-78.
53. Sharawat, S.K.; Bakhshi, R.; Vishnubhatla, S.; Bakhshi, S. Mitochondrial D-loop variations in paediatric acute myeloid leukaemia: a potential prognostic marker. Br. J. Haematol., 2010, 149(3), 391-398.
54. Chen, J.Z.; Kadlubar, F.F. Mitochondrial mutagenesis and oxidative stress in human prostate cancer. Journal of Environmental Science and Health. Part C: Environmental Carcinogenesis & Ecotoxicology Reviews, 2004, 22, 1-12.
55. Yoneyama, H.; Hara, T.; Kato, Y.; Yamori, T.; Matsuura, E.T.; Koike, K. Nucleotide sequence variation is frequent in the mitochondrial DNA displacement loop region of individual human tumor cells. Mol. Cancer Res., 2005, 3, 14-20.
56. Zhai, K.; Chang, L.; Zhang, Q.; Liu, B.; Wu, Y. Mitochondrial C150T polymorphism increases the risk of cervical cancer and HPV infection. Mitochondrion, 2011, 11(4), 559-563.
57. Permuth-Wey, J.; Chen, Y.A.; Tsai, Y.Y.; Chen, Z.; Qu, X.; Lancaster, J.M.; Stockwell, H.; Dagne, G.; Iversen, E.; Risch, H.; Barnholtz-Sloan, J.; Cunningham, J.M.; Vierkant, R.A.; Fridley, B.L.; Sutphen, R.; McLaughlin, J.; Narod, S.A.; Goode, E.L.; Schildkraut, J.M.; Fenstermacher, D.; Phelan, C.M.; Sellers, T.A. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol. Biomarkers Prev., 2011, 20, 1131-1145.
58. Ma, J.T.; Han, C.B.; Zhou, Y.; Zhao, J.Z.; Jing, W.; Zou, H.W. Altered expression of mitochondrial cytochrome c oxidase I and NADH dehydrogenase 4 transcripts associated with gastric tumorigenesis and tumor dedifferentiation. Mol. Med. Report, 2012, 5(6), 1526-1530.
59. He, L.; Luo, L.; Proctor, S.J.; Middleton, P.G.; Blakely, E.L.; Taylor, R.W.; Turnbull, D.M. Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia, 2003, 17(12), 2487-2491.
60. Wang, C.Y.; Wang, H.W.; Yao, Y.G.; Kong, Q.P.; Zhang, Y.P. Somatic mutations of mitochondrial genome in early stage breast cancer. Int. J. Cancer., 2007, 121(6), 1253-1256.
61. Czarnecka, A.M.; Krawczyk, T.; Plak, K.; Klemba, A.; Zdrozny, M.; Arnold, R.S.; Kofler, B.; Golik, P.; Szybinska, A.; Lubinski, J.; Mossakowska, M.; Bartnik, E.; Petros, J.A. Mitochondrial genotype and breast cancer predisposition. Oncol Rep., 2010, 24(6), 1521-1534.
62. Czarnecka, A.M.; Klemba, A.; Krawczyk, T.; Zdrozny, M.; Arnold, R.S.; Bartnik, E.; Petros, J.A. Mitochondrial NADHdehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep., 2010, 23(2), 531-535.
63. Fendt, L.; Niederstätter, H.; Huber, G.; Zelger, B.; Dünser, M.; Seifarth, C.; Röck, A.; Schäfer, G.; Klocker, H.; Parson, W. Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection. Breast Cancer Res. Treat., 2011, 128(2), 327-336.
64. Sanchez-Cespedes, M.; Parrella, P.; Nomoto, S.; Cohen, D.; Xiao, Y.; Esteller, M.; Jeronimo, C.; Jordan, R.C.; Nicol, T.; Koch, W.M.; Schoenberg, M.; Mazzarelli, P.; Fazio, V.M.; Sidransky, D. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res., 2001, 61(19), 7015-7019.
65. Parrella, P.; Seripa, D.; Matera, M.G.; Rabitti, C.; Rinaldi, M.; Mazzarelli, P.; Gravina, C.; Gallucci, M.; Altomare, V.; Flammia, G.; Casalino, B.; Benedetti-Panici, P.L.; Fazio, V.M. Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett., 2003, 190(1), 73-77.
66. Aral, C.; Kaya, H.; Ataizi-Celikel, C.; Akkiprik, M.; Sonmez, O.; Gulluoglu, B.M.; Ozer, A. A novel approach for rapid screening of mitochondrial D310 polymorphism. BMC Cancer, 2006, 6, 21.
67. Zhou, Y.L.; Niu, R.F.; Shi, Y.R. Study on gene control region of mitochondrial DNA in familial breast cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2007, 24(5), 529-532.
68. Yu, M. Somatic mitochondrial DNA mutations in human cancers. Adv. Clin. Chem., 2012, 57, 99-138.
69. Ma, Y.; Bai, R.K.; Trieu, R.; Wong, L.J. Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim. Biophys. Acta, 2010, 1797(1), 29-37.
70. Wei, L.; Zhao, Y.; Guo, T.K.; Li, P.Q.; Wu, H.; Xie, H.B.; Ma, K.J.; Gao, F.; Xie, X.D. Association of mtDNA D-Loop polymorphisms with risk of gastric cancer in chinese population. Pathol. Oncol. Res., 2011, 17(3), 735-742.
71. Santos Jr G.C.; Góoes, A.C.; Vitto, H.d.; Moreira, C.C.; Avvad, E.; Rumjanek, F.D.; Gallo, C.V. Genomic instability at the 13q31 locus and somatic mtDNA mutation in the D-loop site correlate with tumor aggressiveness in sporadic Brazilian breast cancer cases. Clinics (Sao Paulo), 2012, 67(10), 1181-1190.
72. Xu, C.; Tran-Thanh, D.; Ma, C.; May, K.; Jung, J.; Vecchiarelli, J.; Done, S.J. Mitochondrial D310 mutations in the early development of breast cancer. Br. J. Cancer, 2012, 106(9), 1506-1511.
73. Tseng, L.M.; Yin, P.H.; Chi, C.W.; Hsu, C.Y.; Wu, C.W.; Lee, L.M.; Wei, Y.H.; Lee, H.C. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer, 2006, 45(7), 629-638.
74. Ye, C.; Gao, Y.T.; Wen, W.; Breyer, J.P.; Shu, X.O.; Smith, J.R.; Zheng, W.; Cai, Q. Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women. Cancer Epidemiol. Biomarkers Prev., 2008, 17(8), 2117-2122.
75. Bai, R.K.; Leal, S.M.; Covarrubias, D.; Liu, A.; Wong, L.J. Mitochondrial genetic background modifies breast cancer risk. Cancer Res., 2007, 67(10), 4687-4694.
76. Sultana, G.N.; Rahman, A.; Shahinuzzaman, A.D.; Begum, R.A.; Hossain, C.F. Mitochondrial DNA mutations---candidate biomarkers for breast cancer diagnosis in Bangladesh. Chin. J. Cancer, 2012, 31(9), 449-454.
77. Covarrubias, D.; Bai, R.K.; Wong, L.J.; Leal, S.M. Mitochondrial DNA variant interactions modify breast cancer risk. J. Hum. Genet., 2008, 53(10), 924-928.
78. Jakupciak, J.P.; Maggrah, A.; Maragh, S.; Maki, J.; Reguly, B.; Maki, K.; Wittock, R.; Robinson, K.; Wagner, P.D.; Thayer, R.E.; Gehman, K.; Gehman, T.; Srivastava, S.; Ngom, A.; Dakubo, G.D.; Parr, R.L. Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0. BMC Cancer, 2008, 8, 95.
79. Plak, K.; Czarnecka, A.M.; Krawczyk, T.; Golik, P.; Bartnik, E. Breast cancer as a mitochondrial disorder (Review). Oncol. Rep., 2009, 21(4), 845-851.
80. Canter, J.A.; Kallianpur, A.R.; Parl, F.F.; Millikan, R.C. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res., 2005, 65(17), 8028-8033.
81. Darvishi, K.; Sharma, S.; Bhat, A.K.; Rai, E.; Bamezai, R.N. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett., 2007, 249(2), 249-255.
82. Setiawan, V.W.; Chu, L.H.; John, E.M.; Ding, Y.C.; Ingles, S.A.; Bernstein, L.; Press, M.F.; Ursin, G.; Haiman, C.A.; Neuhausen, S.L. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet. Cytogenet., 2008, 181(1), 16-19.
83. Czarnecka, A.M.; Krawczyk, T.; Zdrozny, M.; Lubiski, J.; Arnold, R.S.; Kukwa, W.; Sciska, A.; Golik, P.; Bartnik, E.; Petros, J.A. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res. Treat., 2010, 121(2), 511-518.
84. Pezzotti, A.; Kraft, P.; Hankinson, S.E.; Hunter, D.J.; Buring, J.; Cox, D.G. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One, 2009, 4(4), e5356.
85. Verma, M.; Naviaux, R.K.; Tanaka, M.; Kumar, D.; Franceschi C.; Singh K. Meeting report: mitochondrial DNA and cancer epidemiology. Cancer Res., 2007, 67(2), 437-439.
86. Peng, T.I.; Yu, P.R.; Chen, J.Y.; Wang, H.L.; Wu, H.Y.; Wei, Y.H.; Jou, M.J. Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim. Biophys. Acta, 2006, 1762(2), 241-255.
87. Harding, A.E.; Holt, I.J.; Cooper, J.M.; Schapira, A.H.; Sweeney, M.; Clark, J.B.; Morgan-Hughes, J.A. Mitochondrial myopathies: genetic defects. Biochem. Soc. Trans., 1990, 18(4), 519-522.
88. Dani, M.A.; Dani, S.U.; Lima, S.P.; Martinez, A.; Rossi, B.M.; Soares, F.; Zago, M.A.; Simpson, A.J. Less DeltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet. Mol. Res., 2004, 3(3), 395-409.
89. Shenkar, R.; Navidi, W.; Tavaré, S.; Dang, M.H.; Chomyn, A.; Attardi, G.; Cortopassi, G.; Arnheim, N. The mutation rate of the human mtDNA deletion mtDNA4977. Am. J. Hum. Genet., 1996, 59(4), 772-780.
90. Pavicic, W.H.; Richard, S.M. Correlation analysis between mtDNA 4977-bp deletion and ageing. Mutat. Res., 2009, 670(1-2), 99-102.
91. Wheelhouse, N.M.; Lai, P.B.; Wigmore, S.J.; Ross, J.A.; Harrison, D.J. Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver. Br. J. Cancer, 2005, 92(7), 1268-1272.
92. Bianchi, M.S.; Bianchi, N.O.; Bailliet, G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet. Cell Genet., 1995, 71(1), 99-103.
93. Radpour, R.; Fan, A.X.; Kohler, C.; Holzgreve, W.; Zhong, X.Y. Current understanding of mitochondrial DNA in breast cancer. Breast J., 2009, 15(5), 505-509.
94. Meissner, C.; Bruse, P.; Mohamed, S.A.; Schulz, A.; Warnk, H.; Storm, T.; Oehmichen, M. The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: a useful biomarker or more? Exp. Gerontol., 2008, 43(7), 645-652.
95. Shen, L.; Fang, H.; Chen, T.; He, J.; Zhang, M.; Wei, X.; Xin, Y.; Jiang, Y.; Ding, Z.; Ji, J.; Lu, J.; Bai Y. Evaluating mitochondrial DNA in cancer occurrence and development. Ann. N.Y. Acad. Sci., 2010, 1201, 26-33.
96. Sharp, M.G.; Adams, S.M.; Walker, R.A.; Brammar, W.J.; Varley, J.M. Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue. J. Pathol., 1992, 168, 163-168.
97. Brankovi-Magi, M.; Dobrici, J.; Krivokua, A. Genetics of breast cancer: contribution of BRCA1/2 genes alterations to hereditary predisposition. Vojnosanit Pregl., 2012, 69(8), 700-706.
98. Lee, E.Y. Tumor suppressor genes and their alterations in breast cancer. Semin. Cancer Biol., 1995, 6(3), 119-125.
99. Deng, C.X.; Wang, R.H. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum. Mol. Genet., 2003, 12(1), R113-123.
100. Somasundaram, K. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription. J. Cell Biochem., 2003, 88(6), 1084-1091.
101. Wu, J.; Lu, L.Y.; Yu, X. The role of BRCA1 in DNA damage response. Protein Cell., 2010, 1(2), 117-123.
102. Medema, R.H.; Macrek, L. Checkpoint control and cancer. Oncogene, 2012, 31(21), 2601-2613.
103. Kwong, A.; Ng, E.K.; Wong, C.L.; Law, F.B.; Au, T.; Wong, H.N.; Kurian, A.W.; West, D.W.; Ford, J.M.; Ma, E.S. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. PLoS One, 2012, 7(9), e43994.
104. Pilato, B.; De Summa, S.; Danza, K.; Papadimitriou, S.; Zaccagna, P.; Paradiso, A.; Tommasi, S. DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families. Mol. Biotechnol., 2012, 52(1), 8-15.
105. Ford, D.; Easton, D.F.; Stratton, M.; Narod, S.; Goldgar, D.; Devilee, P.; Bishop, D.T.; Weber, B.; Lenoir, G.; Chang-Claude, J.; Sobol, H.; Teare, M.D.; Struewing, J.; Arason, A.; Scherneck, S.; Peto, J.; Rebbeck, T.R.; Tonin, P.; Neuhausen, S.; Barkardottir, R.; Eyfjord, J.; Lynch, H.; Ponder, B.A.; Gayther, S.A.; Zelada-Hedman, M.; et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 1998, 62(3), 676-689.
106. Zhang, B.; Beeghly-Fadiel, A.; Long, J.; Zheng, W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol., 2011, 12(5), 477-488.
107. Desrichard, A.; Bidet, Y.; Uhrhammer, N.; Bignon, Y.J. CHEK2 contribution to hereditary breast cancer in non-BRCA families. Breast Cancer Res., 2011, 13(6), R119.
108. Easton, D.; Ford, D.; Peto, J. Inherited susceptibility to breast cancer. Cancer Surv., 1993, 18, 95-113.
109. van der Groep, P.; van der Wall, E.; van Diest, P.J. Pathology of hereditary breast cancer. Cell Oncol. (Dordr), 2011, 34(2), 71-88.
110. Ma, J.; Cai, H.; Wu, T.; Sobhian, B.; Huo, Y.; Alcivar, A.; Mehta, M.; Cheung, K.L.; Ganesan, S.; Kong, A.N.; Zhang, D.D.; Xia, B. PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol. Cell. Biol., 2012, 32(8), 1506-1517.
111. Neupert, W. Protein import into mitochondria. Annu. Rev. Biochem., 1997, 66, 863-917.
112. Coene, E.D.; Hollinshead, M.; Waeytens, A.A.; Schelfhout, V.R.; Eechaute, W.P.; Shaw, M.K.; Van Oostveldt, P.M.; Vaux, D.J. Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol. Biol. Cell., 2005, 16(2), 997-1010.
113. Maniccia, A.W.; Lewis, C.; Begum, N.; Xu, J.; Cui, J.; Chipitsyna, G.; Aysola, K.; Reddy, V.; Bhat, G.; Fujimura, Y.; Henderson, B.; Reddy, E.S.; Rao, V.N. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins. J. Cell Physiol., 2009, 219(3), 634-641.
114. Bandiera, S.; Rüberg, S.; Girard, M.; Cagnard, N.; Hanein, S.; Chrétien, D.; Munnich, A.; Lyonnet, S.; Henrion-Caude, A. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One, 2011, 6(6), 20746.
115. Hossein, R.; Houshmand, M. Diagnostic algorithm for identification of individuals with hereditary predisposition to breast cancer. Lik Sprava, 2008, (1-2), 103-108.
116. Kim, H.S.; Patel, K.; Muldoon-Jacobs, K.; Bisht, K.S.; Aykin-Burns, N.; Pennington, J.D.; van der Meer, R.; Nguyen, P.; Savage, J.; Owens, K.M.; Vassilopoulos, A.; Ozden, O.; Park, S.H.; Singh, K.K.; Abdulkadir, S.A.; Spitz, D.R.; Deng, C.X.; Gius, D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell., 2010, 17(1), 41-52.
117. Park, S.H.; Ozden, O.; Jiang, H.; Cha, Y.I.; Pennington, J.D.; Aykin-Burns, N.; Spitz, D.R.; Gius, D.; Kim, H.S. Sirt3, Mitochondrial ROS, Ageing, and Carcinogenesis. Int. J. Mol. Sci., 2011, 12(9), 6226-6239.
118. Jandova, J.; Janda, J.; Sligh, J.E. Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis. Exp. Cell. Res., 2012, 318(17), 2215-2225.
119. Suhane, S.; Berel, D.; Ramanujan, V.K. Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma. Biochem. Biophys. Res. Commun., 2011, 412(4), 590-595.
120. Gochhait, S.; Bhatt, A.; Sharma, S.; Singh, Y.P.; Gupta, P.; Bamezai, R.N. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development-a study in north Indian sporadic breast and esophageal cancer patients. Int. J. Cancer, 2008, 123(11), 2580-2586.
121. Fang, H.; Shen, L.; Chen, T.; He, J.; Ding, Z.; Wei, J.; Qu, J.; Chen, G.; Lu, J.; Bai, Y. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer, 2010, 10, 421.
122. Shen, L.; Wei, J.; Chen, T.; He, J.; Qu, J.; He, X.; Jiang, L.; Qu, Y.; Fang, H.; Chen, G.; Lu, J.; Bai, Y. Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease. J. Cancer Res. Clin. Oncol., 2011, 137(4), 669-675.